Gene therapy for heart failure: The end of the beginning?

Researchers believe Heart Disease could be reversed by introducing a gene into heart cells which would boost the production of a key protein and allow the muscle to recover.

Sian Harding is Professor of Cardiac Pharmacology at the National Heart and Lung Institute, Imperial College, as well as Institute Lead for Women for Athena Swan, and a co-investigator within the UKRMP Immunomodulation Hub.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error: Faculti Content is protected. Please check our Privacy Policy and Terms and Conditions.

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×